Jan Pieter Oosterveld
Director/Board Member at Oosterveld Nederland BV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rafael Fraguas Solé | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| María Amparo Moraleda Martínez | F | 60 |
Instituto de Estudios Superiores de la Empresa
University of Navarra
| - |
| Brian Duperreault | M | 76 |
Instituto de Estudios Superiores de la Empresa
| - |
| Victor Suarez Gonzalez | M | - |
University of Navarra
| - |
| Antonio Trueba Bustamante | M | 81 |
University of Navarra
| - |
| José Manuel G. Martínez-Murillo | M | 66 |
Instituto de Estudios Superiores de la Empresa
| 12 years |
| Michael Steven Rosenberg | M | - |
University of Navarra
| - |
| Xabier Añoveros Trías de Bes | M | - |
University of Navarra
| - |
| Jan Carsten Matthies Estenssoro | M | - |
University of Navarra
| - |
| Diego Fontán Zubizarreta | M | 52 |
Instituto de Estudios Superiores de la Empresa
| - |
| Mercedes Galán Lorda | M | - |
University of Navarra
| - |
| Patricia R. Francis | F | - |
Instituto de Estudios Superiores de la Empresa
| 16 years |
| Stephen Philip Haslett | M | 74 |
University of Navarra
| - |
| Luis María Huete Gómez | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Noelia Fernandez Arroyo | F | - |
University of Navarra
| - |
| Reyes Calderón Cuadrado | M | - |
University of Navarra
| - |
| Andrea Kathrin Christenson | F | 66 |
University of Navarra
| - |
| Polo Looser | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Bert van Meurs | M | - | 39 years | |
| Fuencisla Clemares | F | 50 |
University of Navarra
| 9 years |
| José Alfonso Martín de Cabiedes | M | - |
Instituto de Estudios Superiores de la Empresa
| 11 years |
| Alejandro Bergaz | M | - |
University of Navarra
| - |
| Juan Luis Lopez Cardenete | M | - |
University of Navarra
| - |
| Peter Bamkole | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Socorro Fernández Larrea | F | 59 |
Instituto de Estudios Superiores de la Empresa
| - |
| Luis Julián Martín Carranza Ugarte | M | 58 |
University of Navarra
| - |
| José Antonio Cortajarena Manchado | M | - |
University of Navarra
| - |
| Carlos P. Cavallé | M | 90 |
University of Navarra
| 40 years |
| Pedro Nueno Iniesta | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Juan Ignacio Acha-Orbea Echeverría | M | 67 |
Instituto de Estudios Superiores de la Empresa
| - |
| Raúl González Rodríguez | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Francisco Javier Acebo Sánchez | M | - |
University of Navarra
| - |
| Robert Johnson | M | - |
University of Navarra
| - |
| Abhijit Bhattacharya | M | 62 | 37 years | |
| Carlos González Ojer | M | - |
University of Navarra
| - |
| José María Irisarri Núñez | M | - |
University of Navarra
| - |
| Juan Carlos Vázquez-Dodero de Bonifaz | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Grenville S. Andrews | M | 79 |
University of Navarra
| - |
| Beatriz Goñi Allo | M | - |
University of Navarra
| - |
| Juan Arena de la Mora | M | 80 |
Instituto de Estudios Superiores de la Empresa
| - |
| Enrique Morera Guajardo | M | 69 |
Instituto de Estudios Superiores de la Empresa
| - |
| José Antonio Segarra Torres | M | 68 |
Instituto de Estudios Superiores de la Empresa
| - |
| Ibon Zalbide | M | - |
University of Navarra
| - |
| Francesc Xavier Vives Torrents | M | 69 |
Instituto de Estudios Superiores de la Empresa
| - |
| Alfredo Pastor Bodmer | M | 79 |
University of Navarra
| - |
| Juan José Toribio Dávila | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Ioannis Stavrou | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| Eduardo Martínez Abascal | M | 67 |
University of Navarra
| - |
| Juan Miguel Sucunza Nicasio | M | - |
Instituto de Estudios Superiores de la Empresa
| - |
| José Luis Nueno Iniesta | M | 62 |
Instituto de Estudios Superiores de la Empresa
| - |
| Ignacio Escrivá de Romaní Morales-Arce | M | - |
University of Navarra
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Arnold Hoevenaars | M | 74 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Ronald de Jong | M | 57 | 30 years | |
| Roland Pieper | M | 68 | 1 years | |
| Eric Paul Coutinho | M | 73 | 35 years | |
| Cornelis Josephus A. van Lede | M | 81 | 13 years | |
| Ida Hinkley | F | 73 | 11 years | |
| Maarten de Vries | M | 62 | - | |
| Steven J. Corbett | M | - | 2 years | |
| Mark Williamson | M | 66 | 3 years | |
| Abraham Bout | M | - |
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 14 years |
| Jeff Hewitt | M | 76 | 3 years | |
| David Egan | M | 57 | - | |
| Nelda Connors | F | 58 | 3 years | |
| Marie Paule Richard | M | 72 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Andrew Heath | M | 60 | - | |
| Emma FitzGerald | M | 57 | 3 years | |
| Christopher O’Shea | M | 50 | 3 years | |
| Rick Ertmann | M | - | 27 years | |
| Ricardo Velilla Flores | M | - |
University of Navarra
| 10 years |
| François Clement Wanecq | M | 71 | 5 years | |
| Cees de Jong | M | 63 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | - |
| Arie Westerlaken | M | 78 | - | |
| Ewald Kist | M | 80 | 12 years | |
| John Thompson | M | 81 | 9 years | |
| Johannes Henricus Hommen | M | 81 | 8 years | |
| Gerard Johannes Kleisterlee | M | 76 | 37 years | |
| John Gilbert Sussens | M | 78 | 1 years | |
| Richard Martin Hilary Malthouse | M | 73 | - | |
| Leonard Kruimer | M | 66 |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 14 years |
| Mike Butterworth Butterworth | M | 62 | 1 years | |
| Santiago Baselga Casas | M | - |
University of Navarra
| 6 years |
| Heinrich Gottfried Dutiné | M | 72 | 9 years | |
| Elizabeth Harwerth | F | 77 | 3 years | |
| Floris F. Waller | M | 66 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | 2 years |
| Lodewijk Christian van Wachem | M | 92 | 12 years | |
| Virginia Gomez Onate | F | - |
University of Navarra
| 6 years |
| Hariharan Madhavan | M | - | 17 years | |
| Frans van Houten | M | 64 | 36 years | |
| Ignas van Dommelen | M | - | - | |
| W. de Kleuver | M | 88 | 10 years | |
| René van Schooten | M | 65 | - | |
| Louis Schweitzer | M | 80 | 11 years | |
| Hendrik Jan ten Have | M | - |
University of Navarra
| 2 years |
| Theo van Deursen | M | 78 | - | |
| Richard Greenbury | M | 88 | 12 years | |
| Brendan Walsh | M | 51 | 4 years | |
| Michiel van der Veen | M | - | - | |
| Javier Ribera Lahoz | M | - |
University of Navarra
| 4 years |
| Jeroen Cammeraat | M | 59 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Spain | 54 | 54.00% |
| Netherlands | 31 | 31.00% |
| United Kingdom | 15 | 15.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jan Pieter Oosterveld
- Personal Network
